Cryo-EM structure of key coronavirus protein could help develop vaccines against the virus

Medical workers in China weigh the advantages and disadvantages of nucleic acid lab tests and CT lung scans

Facilities are reopening in China but spread of virus outside China is raising concerns

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak

The tests can still be used, CDC says, as urgency over possible outbreak grows

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Product launches and champagne toasts at instrumentation conference bely worries about infection

Early batches of the test can still be used, CDC says, while affirming it will deploy new kits

Congress opts for open-ended support for federal and local agencies

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery

Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Product launches and champagne toasts belied worries about infection

Gilead toma ventaja gracias a un antiviral, mientras que Moderna está buscando una nueva vacuna ARNm.

C&EN looks at how scientists are adapting to travel restrictions and working from home

Spring lineup of conferences and events frequented by chemists is slashed

Hear what C&EN's pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe

Chemical makers brace for a slowdown on the continent

Several approved and well-studied small molecules could be repurposed as treatments for COVID-19

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking

Congress opts for open-ended support for federal and local agencies

C&EN looks at how scientists are working from home and adapting to travel restrictions

The structure shows the first steps of SARS-CoV-2 infection and could help in drug discovery

Specialty chemical CEOs are rolling with the punches to keep their firms going

Chemical makers and oil producers are pulling back on production, reconsidering investments

The German firm will work with Fosun Pharma and Pfizer to develop an mRNA vaccine for COVID-19

Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations

Amid university shutdowns worldwide, professors and students adjust what social distancing means for lab scientists

Veterans of teaching chemistry online offer advice for professors challenged by the COVID-19 pandemic

Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines

NO₂ levels have fallen sharply in northern Italy and China

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2-specific data are lacking

Companies are making their machines and expertise available to hospitals in need of parts

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for the virus causing COVID-19

Chemistry CROs are back in business as rest of world starts to lock down

Companies are making their machines and expertise available to hospitals in need of parts

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for COVID-19

The National Institutes of Health receives the vast majority of the support

Activists say broad lack of enforcement threatens safety

Auto manufacturing is the first sector to halt demand for chemicals

These biomolecules could hold clues to why the virus is so infectious and to how to stop it

Activists say broad lack of enforcement threatens safety

The National Institutes of Health receives the vast majority of the support